Eight new pharmaceutical clinical trials with a value of more than $40 million are planned after the New South Wales government in Australia supported a joint venture between George Clinical and Guangzhou (China) based pharmaceutical company Link Health at the 28th biennial NSW-Guangdong Joint Economic Meeting. Minister for Trade and Industry Stuart Ayres said George […]
Read MoreBased on its recent analysis of the Asia-Pacific clinical contract research organization (CRO) industry, Frost & Sullivan recognizes George Clinical with the 2021 Asia-Pacific Competitive Strategy Leadership Award. As a leading APAC Clinical CRO company, George Clinical formulates solutions with innovation and scientific leadership to produce high-quality outcomes and maintain growth in the evolving CRO […]
Read MoreOVERLAND PARK, KS. November 11, 2021 – New kidney and metabolic research involving George Clinical teams and scientific leaders has received global attention during the 2021 American Society of Nephrology’s Kidney Week including contributions featured as abstracts, poster sessions, publications and presentations. Despite the restrictions of a global pandemic, meaningful renal clinical research has advanced […]
Read MoreGeorge Clinical scientific leaders and staff members enjoyed significant involvement in the 2021 American Society of Nephrology’s Kidney Week including contributions to abstracts, poster sessions, publications and presentations. Considering the organization’s deep history in kidney and metabolic clinical research, it is unsurprising yet inspiring to see such a broad set of renal research continuing despite […]
Read MoreSYDNEY, October 14, 2021 – Graham Birrell, PhD, MBA, a researcher and neuropharmacologist with significant clinical research experience in the EU and Asia-Pacific region has joined George Clinical, a global scientifically-backed clinical research organization, as Head, Project Operations, APAC. Birrell will also join the scientific leadership of George Clinical with a neurology focus. In his […]
Read MoreThe International IgA Nephropathy Network held the 16th International Symposium on IgA Nephropathy September 21-23 and George Clinical scientific leader Professor Jonathan Barratt presented a key presentation during the first plenary session of the event. Barratt, the Mayer professor of renal medicine at the University of Leicester, presented “RNA Interference in IgAN” on the first day […]
Read MoreGlaxoSmithKline recently announced positive headline results from five studies of the Phase III ASCEND program conducted with George Clinical evaluating the efficacy and safety profile of daprodustat, an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) for patients with anemia due to chronic kidney disease (CKD). The ASCEND program showed that daprodustat met its primary […]
Read MoreGeorge Medicines, a late-stage drug development company focused on providing innovative and accessible medicines for the world’s leading causes of death and a sister company to George Clinical, has initiated two Phase III trials investigating its proprietary triple combination candidate, GMRx2, as a first-line treatment for hypertension. Recent hypertension guidelines recommend combination therapy as initial […]
Read MoreGeorge Clinical’s deep oncology research expertise was on display during the 2021 ASCO Annual Meeting. Several leaders were featured in sessions during the conference including Drs. Lee Schwartzberg, Ari VanderWalde, Herbert Loong, Ralph Boccia, Timothy Pluard and Jason Chandler. Schwartzberg is a co-author on 10 different abstracts that were highlighted in sessions during the virtual event […]
Read MoreSister organization George Medicines, a late-stage drug development company focused on providing innovative and accessible medicines for the world’s leading causes of death, announced the appointment of Stefan König as Chief Executive Officer. George Medicines, a venture-backed spin-out company from The George Institute for Global Health, one of the world’s leading independent medical research institutes, […]
Read More
